(Q36929709)

17 August 2017

0 references

Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl (English)

1 reference

17 August 2017

giant-cell tumor of bone

1 reference

Nicole A Karras

1

1 reference

17 August 2017

Lynda E Polgreen

2

1 reference

17 August 2017

Christian Ogilvie

3

1 reference

17 August 2017

J Carlos Manivel

4

1 reference

17 August 2017

Keith M Skubitz

5

1 reference

17 August 2017

Emily Lipsitz

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

18 March 2013

1 reference

Journal of Clinical Oncology

17 August 2017

1 reference

17 August 2017

31

1 reference

17 August 2017

12

1 reference

17 August 2017

e200-2

1 reference

Denosumab: benefits of RANK ligand inhibition in cancer patients

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Giant cell tumour of bone.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Histological and clinical characteristics of malignant giant cell tumor of bone

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Bisphosphonate-induced osteopetrosis

11 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

11 August 2018

Giant-cell tumor of bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

11 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878007

Gene expression in giant-cell tumors

4 December 2018

1 reference

12 December 2020

Scarcity despite wealth: osteopetrorickets

1 reference

12 December 2020

Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment

1 reference

12 December 2020

Giant-cell tumor of bone in skeletally immature patients

1 reference

12 December 2020

Treatment options for recurrent giant cell tumors of bone

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2012.46.4255

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23509309

1 reference